Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-25-289897
Filing Date
2025-11-20
Accepted
2025-11-20 16:36:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8177
  Complete submission text file 0001193125-25-289897.txt   9583
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Subject) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-39373 | Film No.: 251503525
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1811 AKSARBEN DRIVE OMAHA NE 68106
Business Address
Knudsen Ejnar A III (Filed by) CIK: 0001674241 (see all company filings)

Type: SCHEDULE 13D/A